
Keywords: AA; arachidonic acid; AD; Alzheimer's disease; AMPK; AMP-activated protein kinase; AP-1; activator protein-1; ASCVD; atherosclerotic cardiovascular disease; BBB; blood-brain barrier; BDNF; brain-derived neurotrophic factor; BID; BH3 interacting-domain